Aug 15 (Reuters) - FDA:
FDA: AWARE BAXTER ISSUED LETTER TO AFFECTED CUSTOMERS RECOMMENDING ALL NOVUM IQ LVP, NOVUM IQ SP BE CORRECTED PRIOR TO USE
FDA: RECEIVED THREE REPORTS OF SERIOUS INJURIES AND NO REPORTS OF DEATH ASSOCIATED WITH NOVUM IQ LVP AND NOVUM IQ SP, AS OF JULY 21